Paratransgenic Strategies for the Control of Chagas Disease

  • E. M. Dotson
  • C. B. Beard
Part of the World Class Parasites book series (WCPA, volume 7)


The use of insecticides in the elimination of Chagas disease vectors and therefore in the control of Chagas disease has limitations that have prompted the development of new control approaches. Paratransgenesis utilizes the genetic modification of symbiotic actinomycete bacteria found in the gut of triatomine bugs as a means to modify the gut environment of the bug, rendering it unfavorable to trypanosome development. Paratransgenic control, which has been developed for potential use in conjunction with insecticide programs, shows much promise: stable methods of transformation have been developed, antitrypanosomal genes have been tested, and a means of dispersal has been developed in the form the artificial feces, CRUZIGUARD, which mimics the natural coprophagic transfer of symbionts. Nevertheless, before a pilot field release, gene constructs will need to be optimized and questions concerning the health and environmental risks, as well as political issues, associated with the release of a genetically modified organism must be addressed.


Symbiotic Bacterium Instar Nymph Recombinant Bacterium Shuttle Plasmid Antibiotic Resistance Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aultman KS, Walker ED, Gifford F, Severson DW, Beard CB, Scott TW. 2000. Managing risks of arthropod vector research. Science 288: 2321–2.PubMedCrossRefGoogle Scholar
  2. Beard CB, Aksoy S. 1997. Genetic manipulation of insect symbionts, In: Molecular biology of insect disease vectors, a methods manual. Crampton JM, Beard CB, Louis C. (eds.) Chapman and Hall, London, pp 555–560.Google Scholar
  3. Beard CB, Mason PW, Aksoy S, Tesh RB, Richards FF. 1992. Transformation of an insect symbiont and expression of a foreign gene in the Chagas’ disease vector Rhodnius prolixus. Am J Trop Med Hyg 46: 195–200.PubMedGoogle Scholar
  4. Beard CB, Durvasula RV, Richards FF. 2000. Bacterial symbiont transformation in Chagas disease vectors, In: Insect Transgenesis: Methods and Applications. Handler AM, James AA. (eds.), CRC Press, New York, pp 289–303.Google Scholar
  5. Beard CB, Cordon-Rosales C, Durvasula RV. 2002. Bacterial symbionts of the Triatominae and their potential use in control Chagas disease transmission. Ann Rev Entomol 47: 123–141.CrossRefGoogle Scholar
  6. Christensen B, Fink J, Merrifield RB, Mauzerall D. 1988. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Natl Acad Sci USA 85:5072–6.PubMedCrossRefGoogle Scholar
  7. Dasch GA, Weiss E, Chang K. 1984. Endosymbionts of insects, In: Bergey’s Manual of Systematic Bacteriology. Vol. 1., Krieg NR. (ed.) Williams & Wilkins, Baltimore, MD, pp. 811–833.Google Scholar
  8. Dias J, Schofield C. 1999. The evolution of Chagas disease (American trypanosomiasis control after 90 years since Carlos Chagas’discovery. Mem Inst Oswaldo Cruz 94(Suppl. 1):103–21.PubMedCrossRefGoogle Scholar
  9. Dujardin JP, Munoz M, Chavez T, Ponce C, Moreno J, Schofield CJ. 1998. The origin of Rhodnius prolixus in Central America. Med Vet Entomol 12(1): 113–115.PubMedCrossRefGoogle Scholar
  10. Durvasula RV, Gumbs A, Panackal A, Kruglov O, Aksoy S, Merrifield RB, Richards FF, Beard C.B. 1997. Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc Natl Acad Sci USA 94(7): 3274–8.PubMedCrossRefGoogle Scholar
  11. Durvasula, R.V., Gumbs, A., Panackal, A., Kruglov, O., Taneja, J., Kang, A.S., Cordon-Rosales, C, Richards, F.F., Whitham, R.G., Beard, C.B. 1999a. Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii. Med Vet Entomol 13(2): 115–119.PubMedCrossRefGoogle Scholar
  12. Durvasula RV, Kroger A, Goodwin M, Panackal A, Kruglov O, Taneja J, Gumbs A, Richards FF, Beard CB, Cordon-Rosales C. 1999b. Strategy for introduction of foreign genes into field populations of Chagas disease vectors. Ann Entomol Soc Am. 92(6): 937–943.Google Scholar
  13. Higgs S, Lewis DL. 2000. Green fluorescent protein as a marker for transgenic insects, In: Insect Transgenesis: methods and applications. Handler AM, James AA. (eds.) CRC Press, New York, pp 93–108.Google Scholar
  14. Hoy MA. 2000. Deploying transgenic arthropods in pest management programs: risks and realities, In: Insect Transgenesis: Methods and Applications. Handler AM, James AA. (eds.) CRC Press, New York pp 335–367.Google Scholar
  15. Lee MH, Pascopella L, Jacobs WR, Hatfull GF. 1991. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin. Proc Natl Acad Sci USA 88: 3111–3115.PubMedCrossRefGoogle Scholar
  16. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR Jr. Bloom RB. 1991. New use of BCG for recombinant vaccines. Nature 351: 456–460.PubMedCrossRefGoogle Scholar
  17. Vassena CV, Picollo MI, Zerba EN. 2000. Insecticide resistance in Brazilian Triatoma infestans and Venezuelan Rhodnius prolixus. Med Vet Entomol 14: 51–55.PubMedCrossRefGoogle Scholar
  18. Via LE, Dhandayuthapani S, Deretic D, Deretic V. 1998. Green fluorescent protein, a tool for gene expression and cell biology in mycobacteria. In: Mycobacteria Protocols. Parish T, Stoker NG (eds), Humana Press, Totowa, New Jersey, pp. 245–260.Google Scholar
  19. Young OP, Ingebritsen SP, Foudin AS. 2000. Regulation of transgenic arthropods and other invertebrates in the United States, In: Insect Transgenesis: Methods and Applications. Handler AM, James AA. (eds.) CRC Press, New York pp 369–379.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • E. M. Dotson
    • 1
  • C. B. Beard
    • 1
  1. 1.Centers for Disease Control and Prevention, NCID, DPDGAUSA

Personalised recommendations